QQQ $ 479.30 $ 2.47 (0.52 %)
DIA $ 386.46 $ -0.42 (-0.11 %)
SPY $ 542.65 $ 0.33 (0.06 %)
TLT $ 94.67 $ 0.79 (0.84 %)
GLD $ 215.76 $ 2.76 (1.3 %)
$ na
-- x --
-- x --
-- - --
na - na
0
na
na
na
na
TBD
na
na (na)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 irwin-naturals-acquires-ketamine-clinic-in-kentucky-adding-3m-in-projected-ebitda

Irwin Naturals Inc. (OTCQB: IWINF) (CSE:IWIN) (FRA:97X) has successfully completed the acquisition of Serenity Health, LLC, a k...

 irwin-naturals-signs-loi-to-acquire-braxia-scientific-expanding-its-network-of-mental-health-clinics

Irwin Naturals Inc.

 braxia-scientific-q2-2023-financial-results-health-clinic-ketamine-treatments-increases-345-yoy

Braxia Scientific Corp., (CSE: BRAX) (OTC: BRAXF) (FWB: 4960), a medical research and telemedicine company with clinics providi...

 braxia-opens-new-clinic-in-ontario-facilitating-further-access-to-ketamine-and-psilocybin-treatments

Braxia Scientific Corp.

 psyched-elon-musk-discusses-psychedelics-delix-raises-70m-mindcure-to-study-mdma-in-female-sexual-dysfunction

The Week In Psychedelics:

 new-study-suggests-ketamine-could-work-better-without-additional-antidepressants

Braxia Scientific Corp. (CSE: BRAX) (OTC: BRAXF) released results of a clinical study suggesting that ketamine could be as effe...

 psyched-cybin-gets-9-price-target-fsd-pharma-acquires-lucid-new-trials-from-psilera-awakn-pharmadrug-and-braxia-california-bill-put-on-hold

Contents

 braxia-scientific-launches-broad-criteria-trial-on-psilocybin-for-depression

Braxia Scientific Corp. (CSE: BRAX) (OTC: BRAXF), a Toronto-based psychedelics company, is launching a randomized clinical tria...

 braxia-scientific-leadership-receives-funding-from-canadian-government-to-study-ketamine-therapy

Braxia Scientific Corp (CSE: BRAX) (OTC: BRAXF), a Toronto-based company that provides

 canadian-insurance-provider-to-cover-off-label-use-of-ketamine-for-treating-depression

Braxia Scientific Corp. (CSE: BRAX) (OTC: BRAXF), a medical research company in the psychedelics space, recently announced that...

 psyched-gh-research-debuts-on-nasdaq-compass-reaches-psilocybin-research-milestone-maxim-gives-buy-rating-to-10-psychedelics-companies

Irish 5-MeO-DMT Company GH Research Debuts On Nasdaq GH Research, a Dublin-based company studying the potential of 5-MeO-DMT f...

 psyched-atai-life-sciences-hits-nasdaq-canada-to-fund-ketamine-trials-mydecine-launches-ai-drug-discovery-platform

Atai Life Sciences (NASDAQ: ATAI) made its highly-anticipated Nasdaq debut on Friday.

 psyched-mindmed-and-compass-q1-earnings-fda-approves-therapists-taking-mdma-wesana-health-goes-public

Two of the most prominent companies in the psychedelics space released their financials for the first quarter of 2021.

 cannabis-countdown-top-10-marijuana-and-psychedelic-stock-news-stories-of-the-week

Welcome to the Cannabis Countdown, the Legal Marijuana Industry’s Number One Curated Weekly News Recap. In This Week’s Edition...